Published in J Pain Res on January 20, 2017
The role of miR-190a-5p contributes to diabetic neuropathic pain via targeting SLC17A6. J Pain Res (2017) 0.75
Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 25.43
Cellular and molecular mechanisms of pain. Cell (2009) 9.36
Neuronal plasticity: increasing the gain in pain. Science (2000) 8.85
Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care (2005) 7.81
Molecular mechanisms of nociception. Nature (2001) 7.75
Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain (2009) 7.11
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol (2015) 5.57
Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. JAMA (2015) 5.20
Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci (1984) 4.87
painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin (2006) 4.78
The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain (2001) 3.90
Prevalence of chronic pain with neuropathic characteristics in the general population. Pain (2007) 3.72
The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain (2006) 3.67
A new definition of neuropathic pain. Pain (2011) 3.57
State-dependent opioid control of pain. Nat Rev Neurosci (2004) 3.51
The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care (2003) 3.12
The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care (2006) 3.03
Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest (2003) 2.95
Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med (2001) 2.91
Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev (2009) 2.83
Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons. J Physiol (2006) 2.62
Diabetic neuropathy: mechanisms to management. Pharmacol Ther (2008) 2.57
Attacking pain at its source: new perspectives on opioids. Nat Med (2003) 2.53
Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain (2006) 2.51
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum (2004) 2.48
Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci (2001) 2.33
Does the prevailing hypothesis that small-fiber dysfunction precedes large-fiber dysfunction apply to type 1 diabetic patients? Diabetes Care (2014) 2.29
A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain (2001) 2.28
The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes (2002) 2.20
Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes (2004) 2.02
Statins and risk of polyneuropathy: a case-control study. Neurology (2002) 1.97
The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain (2004) 1.90
Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev (2014) 1.86
Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology (1987) 1.85
Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes (2004) 1.79
Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci U S A (2002) 1.76
The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin. J Neurosci (2009) 1.73
Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials. J Womens Health (Larchmt) (2007) 1.69
Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons. J Neurosci (2007) 1.69
Spinal dorsal horn calcium channel alpha2delta-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia. J Neurosci (2004) 1.66
Paclitaxel-induced neuropathy. Ann Oncol (1995) 1.65
Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol (2011) 1.65
Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology (2001) 1.60
Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol (2005) 1.58
Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. Diabetes Care (2004) 1.58
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J Pharmacol Exp Ther (2004) 1.53
Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain (2013) 1.51
Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Physiol Rev (2014) 1.51
Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes (2005) 1.50
Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology (2011) 1.50
The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation. J Neurosci (2000) 1.48
Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain (2004) 1.47
Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology (2003) 1.46
The cutaneous sensory system. Neurosci Biobehav Rev (2009) 1.41
Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev (2014) 1.41
Clinical usefulness of laser-evoked potentials. Neurophysiol Clin (2003) 1.40
Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Ann Neurol (2003) 1.39
Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach. Lancet Neurol (2012) 1.37
Calcium channel alpha(2)delta subunits-structure and Gabapentin binding. Mol Pharmacol (2001) 1.33
Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy. Diabetes (2006) 1.32
Taxol produces a predominantly sensory neuropathy. Neurology (1989) 1.32
Spinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the rat. Neurosci Lett (2006) 1.30
Spinal mechanisms of acute and persistent pain. Reg Anesth Pain Med (1999) 1.29
B-COMPLEX VITAMINS IN LIVER DISEASE OF THE ALCOHOLIC. Am J Clin Nutr (1965) 1.29
Neuropathic pain: emerging treatments. Br J Anaesth (2008) 1.28
Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol (2005) 1.26
Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance. J Neurosci (2004) 1.26
Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ. Neurosci Lett (1996) 1.25
Role of spinal cord alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in complete Freund's adjuvant-induced inflammatory pain. Mol Pain (2008) 1.24
Key role for the epsilon isoform of protein kinase C in painful alcoholic neuropathy in the rat. J Neurosci (2000) 1.23
Idiopathic neuropathy, prediabetes and the metabolic syndrome. J Neurol Sci (2006) 1.23
Delta and kappa opioid receptors as suitable drug targets for pain. Clin J Pain (2010) 1.23
Are voltage-gated sodium channels on the dorsal root ganglion involved in the development of neuropathic pain? Mol Pain (2011) 1.23
Effects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain (2001) 1.21
Thermoreceptive innervation of human glabrous and hairy skin: a contact heat evoked potential analysis. Pain (2005) 1.21
Taxol-induced neuropathy: short-term effects of local injection. J Neurocytol (1984) 1.19
Small fiber neuropathy: a common and important clinical disorder. J Neurol Sci (2004) 1.19
Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain. Pain (2006) 1.17
Quantitative sensory findings in patients with bortezomib-induced pain. J Pain (2006) 1.16
Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey. Acta Anaesthesiol Scand (2007) 1.16
Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers. Br J Anaesth (2007) 1.16
Antinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys. J Pain (2009) 1.14
Quick discrimination of A(delta) and C fiber mediated pain based on three verbal descriptors. PLoS One (2010) 1.14
Poly(ADP-ribose) polymerase inhibitors. Curr Med Chem (2003) 1.12
Neuropathic pain is enhanced in delta-opioid receptor knockout mice. Eur J Neurosci (2006) 1.12
Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey. Diabetes Metab Syndr Obes (2013) 1.10
Impairment of thiamine absorption in alcoholism. Am J Clin Nutr (1968) 1.10
C- and A delta-fiber components of heat-evoked cerebral potentials in healthy human subjects. Pain (1999) 1.07
Low-dose poly(ADP-ribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathy. Diabetes (2005) 1.07
Taxol-induced neuropathy: chronic effects of local injection. J Neurocytol (1986) 1.06
Abnormal function of C-fibers in patients with diabetic neuropathy. J Neurosci (2006) 1.04
Mechanisms of thiamin deficiency in chronic alcoholism. Am J Clin Nutr (1980) 1.04
Contact heat evoked potentials as a valid means to study nociceptive pathways in human subjects. Neurosci Lett (2001) 1.03
Injury discharges regulate calcium channel alpha-2-delta-1 subunit upregulation in the dorsal horn that contributes to initiation of neuropathic pain. Pain (2008) 1.02
Delta Opioid Pharmacology in Relation to Alcohol Behaviors. Handb Exp Pharmacol (2016) 0.75